Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Parkinsonism Relat Disord. 2011 Jan 17;17(3):212–214. doi: 10.1016/j.parkreldis.2010.12.014

Table 1.

Controls PD+ICB PD-ICB t value
except * and **
p-value
Participants (no.) 24 28 24
Age (yrs) 57.8 ± 10.7 54.6 ± 9.2 64,2 ±10.1 F = 7.0 ** = 0.002
Gender (male) 14 21 21 χ 2 = 5.3 * =0.071
At disease onset - 44.5 ± 8.7 52.5 ± 9.6 t = 3.1 =0.03

Disease duration (yrs) - 10.1 ± 5.5 11.7 ± 7.2 t = 0.88 =0.39
Education (yrs) 13.2 ± 2.9 13.4 ± 3.0 14.7 ± 3.6 F = 1.7 ** =0.18

LEU dose(mg/day) - 832 ± 425 821 ± 400 t = 0.1 =0.9
DA (patients) - 14 16 χ 2 = 1.4 =0.27
Antidepressants
(patients)
- 4 2 χ 2 = 0.45 =0.4

UPDRS on - 15.5 ± 8.3 14.4 ± 5.8 t = 0.5 =0.6
UPDRS off - 27.3 ± 9.1 26.8 ± 6.7 t = 0.2 =0.8
Improvement in
UPRDS (%)
- 43.2 46.2

Gambling - 11 -
Hypersexuality - 13 -
Shopping - 8 -
Punding - 4 -
Kleptomania - 1 -

UPDRS = Unified Parkinson’s Disease Rating Scale; LEU = L-dopa equivalent units; DA = dopamine agonists. All values are mean ± SD.

*

= Chi-square

**

= F value.